Symbiotec Pharmalab Ltd.

Held by 60 funds in our universe · avg weight 0.47% · range 0.01% to 2.31%

Fundamentals

Current price ₹1197.5

Market cap —

P/E (TTM) —

P/B —

ROE —

Debt / equity —

Revenue growth —

Profit margin —

Dividend yield —

Technicals · split/bonus-adjusted

From 52-wk high -6.4%

52-week high ₹1279.5

52-week low ₹1003.4

200-day MA ₹1128.3

vs 200D MA +6.1%

Worst drop 3y -13.2%

Worst drop all-time -13.2%

Market-cap class —

Price as of 2026-10-22

Funds by category

All (60) Equity – Sectoral/ Thematic (13) Equity – Small Cap Fund (8) Equity – Flexi Cap Fund (6) Equity – Multi Cap Fund (4) Hybrid – Dynamic Asset Allocation or Balanced Advantage (4) Hybrid – Multi Asset Allocation (4) Hybrid – Aggressive Hybrid Fund (3) Equity – ELSS (3) Equity – Large & Mid Cap Fund (2) Equity – Large Cap Fund (2) Equity – Mid Cap Fund (2) Hybrid – Equity Savings (2) Equity – Dividend Yield Fund (2) Equity – Focused Fund (1) Solution Oriented – Children’s Fund (1) Equity – Growth (legacy) (1) Equity – Value Fund (1) Solution Oriented – Retirement Fund (1)

Showing only Equity – Mid Cap Fund funds. clear filter

2 Equity – Mid Cap Fund funds holding this stock , sorted by the stock's weight in each fund

Fund	Category	% of fund in this stock	As of
Mirae Asset Midcap Fund - Direct Plan - Growth Mirae Asset Mutual Fund	Equity · Mid Cap Fund	0.45%	2026-09-30
Baroda BNP Paribas Mid Cap Fund - Direct Plan - Growth Option Baroda BNP Paribas Mutual Fund	Equity · Mid Cap Fund	0.01%	2026-08-31

Holdings sourced from scheme portfolios as published by their AMCs each month under SEBI rules. "% of fund in this stock" is the position weight inside each fund, NOT the rupee value of any individual investor's exposure.